Winfield Associates’s CRISPR Therapeutics CRSP Stock Holding History

Winfield Associates’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell
2021 Q4	$205K	Sell
2021 Q3	$453K	Sell
2021 Q2	$737K	Buy
2021 Q1	$518K	Buy
2020 Q4	$236K	Buy